Welsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters

November 9, 2021

Welsh, Carson, Anderson & Stowe (WCAS) acquired a majority ownership stake in Leiters, an FDA-registered 503B outsourced pharmaceutical compounding provider. WCAS invested alongside health system investors including Intermountain Ventures, Novant Health, Rex Health Ventures, Spectrum Health Ventures and UNC Health, while existing investors — including Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors and H.I.G. BioHealth Partners — made reinvestments to support Leiters' growth, facility expansion and new product development.

Buyers
Welsh, Carson, Anderson & Stowe, Intermountain Ventures, Novant Health, Rex Health Ventures, Spectrum Health Ventures, UNC Health, Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors, H.I.G. BioHealth Partners
Targets
Leiters
Sellers
Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors, H.I.G. BioHealth Partners
Industry
Pharmaceuticals
Location
Colorado, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.